Colgate-palmo receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Colgate-Palmolive Company (CL)
Colgate-Palmolive Company stock price live, this page displays NYSE CL stock exchange data. View the CL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Colgate-Palmolive Company real time stock price chart below.
What Is the Colgate-Palmolive Company Stock Price Today?
The Colgate-Palmolive Company stock price today is 94.88.
What Is the Stock Symbol for Colgate-Palmolive Company?
The stock symbol for Colgate-Palmolive Company is "CL."
What Stock Exchange Does Colgate-Palmolive Company Trade On?
Colgate-Palmolive Company is listed and trades on the NYSE stock exchange.
Is Colgate-Palmolive Company a Good Stock to Buy?
Determining whether Colgate-Palmolive Company—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CL quote. (ISIN: US1941621039)
What Is the Colgate-Palmolive Company Stock Price Today?
The Colgate-Palmolive Company stock price today is 94.88.
What Is the Stock Symbol for Colgate-Palmolive Company?
The stock symbol for Colgate-Palmolive Company is "CL."
What Stock Exchange Does Colgate-Palmolive Company Trade On?
Colgate-Palmolive Company is listed and trades on the NYSE stock exchange.
Is Colgate-Palmolive Company a Good Stock to Buy?
Determining whether Colgate-Palmolive Company—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CL quote. (ISIN: US1941621039)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
93.25
95.49
52 wk Range
74.55
100.18
CL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
93.2595.49
52 wk Range
74.55100.18
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
95.32
Upside
+0.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
7 analysts have revised their earnings upwards for the upcoming period
- Colgate-palmo receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Colgate-palmo receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Colgate-palmo receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Colgate-Palmolive Company Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill’s Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill’s Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Colgate-Palmolive Company SWOT Analysis
Global Market Leade | Colgate-Palmolive's strong brand portfolio and successful 2025 strategy position it as a formidable player in the consumer goods secto |
Navigating Challenges | Explore how the company addresses currency fluctuations, category slowdowns, and competitive pressures while maintaining impressive profit margins |
Future-Focused Strategy | Delve into Colgate-Palmolive's 2030 strategy and three-year restructuring program aimed at unlocking growth potential and enhancing operational efficiency |
Analyst Perspectives | Discover varied price targets ranging from $87 to $97, reflecting analysts' views on Colgate-Palmolive's growth prospects and market positioning |
Colgate-Palmolive Company Earnings Call Summary for Q4/2025
- Colgate-Palmolive exceeded Q4 2025 forecasts with EPS of $0.95 vs $0.91 and revenue of $5.23B vs $5.12B, driving a 3.65% pre-market stock increase to $88.35.
- The company reported record operating cash flow of $4.2B and 4.5% organic growth in emerging markets, despite volatile conditions in North America.
- CEO Noel Wallace highlighted growth across organic sales, net sales, gross profit, base business EPS, and free cash flow for fiscal year 2025.
- For 2026, Colgate-Palmolive projects organic sales growth of 1-4%, with North American challenges expected to improve in the second half of the year.
- Strategic initiatives including the Strategic Growth and Productivity Program and investments in digital and AI capabilities are positioned to support future growth.
Last Updated: 2026-01-30, 09:38 a/m
Read Full TranscriptCompare CL to Peers and Sector
Metrics to compare | CL | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipCLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 35.9x | 26.6x | 12.2x | |
PEG Ratio | −1.43 | −3.05 | 0.03 | |
Price/Book | 1,416.3x | 6.8x | 1.5x | |
Price / LTM Sales | 3.8x | 2.4x | 0.9x | |
Upside (Analyst Target) | 1.2% | 0.7% | 16.9% | |
Fair Value Upside | Unlock | 6.4% | 11.4% | Unlock |
Analyst Ratings
12 Buy
6 Hold
1 Sell
Ratings:
19 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 95.32
(+0.46% Upside)
Earnings
Latest Release
Jan 30, 2026
EPS / Forecast
0.95 / 0.91
Revenue / Forecast
5.23B / 5.12B
People Also Watch
FAQ
What Is the Colgate-Palmolive (CL) Stock Price Today?
The Colgate-Palmolive stock price today is 94.88
What Stock Exchange Does Colgate-Palmolive Trade On?
Colgate-Palmolive is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Colgate-Palmolive?
The stock symbol for Colgate-Palmolive is "CL."
Does Colgate-Palmolive Pay Dividends? What’s The Current Dividend Yield?
The Colgate-Palmolive dividend yield is 2.19%.
What Is the Colgate-Palmolive Market Cap?
As of today, Colgate-Palmolive market cap is 76.48B.
What Is Colgate-Palmolive's Earnings Per Share (TTM)?
The Colgate-Palmolive EPS (TTM) is 2.63.
When Is the Next Colgate-Palmolive Earnings Date?
Colgate-Palmolive will release its next earnings report on Apr 24, 2026.
From a Technical Analysis Perspective, Is CL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Colgate-Palmolive Stock Split?
Colgate-Palmolive has split 5 times.
How Many Employees Does Colgate-Palmolive Have?
Colgate-Palmolive has 34000 employees.
What is the current trading status of Colgate-Palmolive (CL)?
As of Feb 06, 2026, Colgate-Palmolive (CL) is trading at a price of 94.88, with a previous close of 94.88. The stock has fluctuated within a day range of 93.25 to 95.49, while its 52-week range spans from 74.55 to 100.18.
What Is Colgate-Palmolive (CL) Price Target According to Analysts?
The average 12-month price target for Colgate-Palmolive is USD95.32, with a high estimate of USD105 and a low estimate of USD84. 12 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +0.46% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.